Hankosky ER, Wang H, Neff LM, Kan H, et al. Tirzepatide reduces the predicted risk of developing type 2 diabetes in people with obesity or overweight: Post hoc analysis of the SURMOUNT-1 trial. Diabetes Obes Metab 2023 Sep 12. doi: 10.1111/dom.15269.
PMID: 37700443